Barclays Maintains Overweight on Aveanna Healthcare Hldgs, Raises Price Target to $15
Barclays analyst Andrew Mok maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Overweight and raises the price target from $9.5 to $15.
Stocks · News reference
Truist Securities Maintains Hold on Aveanna Healthcare Hldgs, Raises Price Target to $15
Truist Securities analyst David Macdonald maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Hold and raises the price target from $11 to $15.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
8-K filing — Aveanna Healthcare Holdings, Inc. (AVAH)
Filed: 2026-08-24 AccNo: 0001193125-26-363654 Size: 520 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Aveanna Healthcare shares are trading higher after RBC Capital maintained its Outperform rating on the stock and raised its price target from $10 to $16.